MDGS - メディガス （Medigus Ltd.）

Medigus press release (MDGS): Q1 GAAP EPS of -$0.40.Revenue of $91.8M (+807.1% Y/Y).

Record Revenues of approx. $92 million, up over 800% Y-o-Y Record Revenues of approx. $92 million, up over 800% Y-o-Y

A technology company engaged in advanced medical solutions, Medigus (MDGS) has acquired 19.9% of Metagramm Software, an innovative AI, ML communication and grammar assistant…

Medigus press release (MDGS): FY Revenue of $0.96M.Net profit for the fiscal year ended December 31, 2022 rose to $1,117 thousand compared to $591 thousand in 2021.Net cash from…

Viewbix is a subsidiary of Gix Internet whose results are consolidated with Medigus’ financial statements

https://www.investing.com/news/assorted/medigus-announces-jeffs-brands-entered-into-nonbinding-loi-with-superbuzz-for-developing-aibased-software-for-amazons-ad-platform-432SI-3012414

Tel Aviv, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Jeffs'' Brands Ltd. (“Jeffs’ Brands”) (owned 35.94% by Medigus) a data-driven E-commerce company operating on the Amazon Marketplace, has entered into a non-binding letter of Intent (the “LOI”) to collaborate with SuperBuzz Inc. (“SuperBuzz”), an artificial intelligence (AI) company specializing in marketing technology.

Medigus (MDGS) on Thursday announced the details of its $1.6M cash capital distribution.The firm will distribute cash capital of $0.85 per American depositary share to ADS holders…

Nasdaq has notified technology company Medigus (MDGS) of having regained compliance with the stock exchange''s listing rules.

Medigus (MDGS) has announced that, the Tel Aviv District Court Economic Department approved the Co.’s motion for the approval of a cash capital distribution of up to $1.6M

Medigus Ltd. (NASDAQ:MDGS)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting 1.53. At the close of trading, the stock’s price was $0.55, to imply a decrease of -6.45% or -$0.04 in intraday trading. The MDGS share’s 52-week high remains $1.78, putting it -223.64% down since that peak … Medigus Ltd. (NASDAQ: MDGS) Has Succeeded To Excite In 2022, The Stock Is Down -45.00% Year-To-Date Read More »

In recent trading session, Medigus Ltd. (NASDAQ:MDGS) saw 2.56 million shares changing hands at last check today with its beta currently measuring 1.52. Company’s recent per share price level of $0.59 trading at $0.05 or 9.54% at last check today assigns it a market valuation of $48.39M. That most recent trading price of MDGS’s stock … Medigus Ltd. (NASDAQ:MDGS) Stock Has Fallen -46.14% YTD, What Do Analysts Anticipate Next? Read More »

Medigus press release (MDGS): 1H Net loss of $4.75MRevenue of $34.95M (+1362.3% Y/Y).Cash and cash equivalents as of June 30, 2022 were $22.1 millionShareholders’ equity improved to…

Record Revenues of $34.95 million, up over 1,300% Y-o-Y Record Revenues of $34.95 million, up over 1,300% Y-o-Y

Tel Aviv, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Polyrizon Ltd. ("Polyrizon"), a privately held company in which Medigus owns 37.03%, has submitted a PCT (Patent Cooperation Treaty) application,